FDA Approved: FRAGMIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Fragmin (dalteparin sodium) submitted by Pfizer Laboratories Div Pfizer Inc. The action indicates approval of a supp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• FRAGMIN (DALTEPARIN SODIUM)

Snippet

SUPPL AP for FRAGMIN (DALTEPARIN SODIUM)